SELLAS Life Sciences Group, Inc. (SLS)
8.03
-0.39
(-4.63%)
USD |
NASDAQ |
Nov 12, 16:00
9.47
+1.44
(+17.93%)
After-Hours: 06:32
SELLAS Life Sciences Group Market Cap : 1.621B for Nov. 12, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 12, 2026 | 1.621B |
| November 11, 2026 | 1.700B |
| November 10, 2026 | 1.690B |
| November 09, 2026 | 1.732B |
| November 06, 2026 | 1.700B |
| November 05, 2026 | 1.591B |
| November 04, 2026 | 1.846B |
| November 03, 2026 | 1.791B |
| November 02, 2026 | 1.726B |
| October 30, 2026 | 1.955B |
| October 29, 2026 | 2.050B |
| October 28, 2026 | 2.096B |
| October 27, 2026 | 2.457B |
| October 26, 2026 | 2.290B |
| October 23, 2026 | 2.330B |
| October 22, 2026 | 2.292B |
| October 21, 2026 | 2.451B |
| October 20, 2026 | 2.419B |
| October 19, 2026 | 2.118B |
| October 16, 2026 | 2.015B |
| October 15, 2026 | 2.290B |
| October 14, 2026 | 2.399B |
| October 13, 2026 | 2.506B |
| October 12, 2026 | 2.409B |
| October 09, 2026 | 2.352B |
| Date | Value |
|---|---|
| October 08, 2026 | 2.274B |
| October 07, 2026 | 2.284B |
| October 06, 2026 | 2.290B |
| October 05, 2026 | 2.348B |
| October 02, 2026 | 2.371B |
| October 01, 2026 | 2.288B |
| September 30, 2026 | 2.486B |
| September 29, 2026 | 2.324B |
| September 28, 2026 | 2.340B |
| September 25, 2026 | 2.344B |
| September 24, 2026 | 2.419B |
| September 23, 2026 | 2.326B |
| September 22, 2026 | 2.427B |
| September 21, 2026 | 2.296B |
| September 18, 2026 | 2.320B |
| September 17, 2026 | 2.328B |
| September 16, 2026 | 2.354B |
| September 15, 2026 | 2.280B |
| September 14, 2026 | 2.367B |
| September 11, 2026 | 2.331B |
| September 10, 2026 | 2.724B |
| September 09, 2026 | 2.817B |
| September 08, 2026 | 2.819B |
| September 04, 2026 | 2.799B |
| September 03, 2026 | 2.766B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| AbbVie, Inc. | 520.44B |
| ImmunityBio, Inc. | 6.457B |
| TG Therapeutics, Inc. | 9.759B |
| Capricor Therapeutics, Inc. | 595.34M |
| Relay Therapeutics, Inc. | 3.969B |
Market Cap Related Metrics
| Price to Book Value | 11.78 |
| Price | 8.03 |
| Earnings Yield | -2.64% |